Elisabet Matas

556 total citations
23 papers, 419 citations indexed

About

Elisabet Matas is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Elisabet Matas has authored 23 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 9 papers in Rheumatology and 4 papers in Neurology. Recurrent topics in Elisabet Matas's work include Multiple Sclerosis Research Studies (19 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Peripheral Neuropathies and Disorders (4 papers). Elisabet Matas is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Peripheral Neuropathies and Disorders (4 papers). Elisabet Matas collaborates with scholars based in Spain, Sweden and United Kingdom. Elisabet Matas's co-authors include Sergio Martínez‐Yélamos, Laura Bau, Lucía Romero, M. Alba Mañé-Martínez, Henrik Zetterberg, Bob Olsson, Kaj Blennow, Ulf Andréasson, Álvaro Cobo‐Calvo and Albert Muñoz‐Vendrell and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Elisabet Matas

22 papers receiving 410 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Elisabet Matas 306 128 93 65 64 23 419
Laura Bau 315 1.0× 143 1.1× 96 1.0× 61 0.9× 64 1.0× 24 405
E. P. Evdoshenko 265 0.9× 153 1.2× 73 0.8× 65 1.0× 71 1.1× 34 364
Johanna Oechtering 200 0.7× 115 0.9× 63 0.7× 45 0.7× 86 1.3× 22 358
M. Alba Mañé-Martínez 205 0.7× 103 0.8× 48 0.5× 46 0.7× 52 0.8× 10 270
Carolina Rush 252 0.8× 83 0.6× 49 0.5× 85 1.3× 41 0.6× 17 314
Elisabetta Verdun di Cantogno 380 1.2× 139 1.1× 98 1.1× 93 1.4× 36 0.6× 23 437
Takeshi Kezuka 153 0.5× 124 1.0× 124 1.3× 42 0.6× 65 1.0× 20 495
Johan Mellergård 215 0.7× 63 0.5× 52 0.6× 80 1.2× 88 1.4× 22 394
Aidan Droogan 291 1.0× 60 0.5× 83 0.9× 81 1.2× 91 1.4× 21 535
Laura Willis 305 1.0× 86 0.7× 79 0.8× 52 0.8× 60 0.9× 9 376

Countries citing papers authored by Elisabet Matas

Since Specialization
Citations

This map shows the geographic impact of Elisabet Matas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Matas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Matas more than expected).

Fields of papers citing papers by Elisabet Matas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabet Matas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Matas. The network helps show where Elisabet Matas may publish in the future.

Co-authorship network of co-authors of Elisabet Matas

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabet Matas. A scholar is included among the top collaborators of Elisabet Matas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabet Matas. Elisabet Matas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matas, Elisabet, Laura Bau, Lucía Romero, et al.. (2025). Benign multiple sclerosis and long-term outcomes after 30 years. Journal of Neurology. 272(11). 747–747.
2.
Naval‐Baudin, Pablo, Antonio Martı́nez-Yélamos, Albert Muñoz‐Vendrell, et al.. (2025). The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 103. 106658–106658. 3 indexed citations
3.
Bau, Laura, Elisabet Matas, Lucía Romero, et al.. (2024). Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort. Neurological Sciences. 46(1). 335–342. 2 indexed citations
4.
Morandeira, Francisco, Albert Muñoz‐Vendrell, Elisabet Matas, et al.. (2023). Kappa free light chains index in multiple sclerosis very long-term prognosis. Frontiers in Immunology. 14. 1223514–1223514. 7 indexed citations
5.
Muñoz‐Vendrell, Albert, Laura Bau, Elisabet Matas, et al.. (2023). Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort. Journal of Neurology. 271(4). 1599–1609. 19 indexed citations
6.
Muñoz‐Vendrell, Albert, Laura Bau, Elisabet Matas, et al.. (2022). Influence of Cardiovascular Risk Factors in Early Relapsing-Remitting Multiple Sclerosis: A Retrospective Analysis. European Neurology. 86(1). 73–77. 2 indexed citations
7.
Romero, Lucía, Laura Bau, Elisabet Matas, et al.. (2022). The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades. Multiple Sclerosis and Related Disorders. 68. 104103–104103. 41 indexed citations
8.
Mañé-Martínez, M. Alba, Bob Olsson, Laura Bau, et al.. (2016). Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis. Journal of Neuroimmunology. 299. 112–117. 56 indexed citations
9.
Cobo‐Calvo, Álvaro, Albert Figueras, Laura Bau, et al.. (2016). Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis. Clinical Immunology. 171. 18–24. 6 indexed citations
10.
Matas, Elisabet, Laura Bau, María Martínez‐Iniesta, et al.. (2016). Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients. Journal of Neurology. 263(4). 722–729. 7 indexed citations
11.
Matas, Elisabet, Laura Bau, María Martínez‐Iniesta, et al.. (2015). MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients. Journal of Neuroimmunology. 291. 73–77. 4 indexed citations
12.
Matas, Elisabet, Laura Bau, María Martínez‐Iniesta, et al.. (2014). Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients. PLoS ONE. 9(11). e112758–e112758. 12 indexed citations
13.
Cobo‐Calvo, Álvaro, Agustí Alentorn, M. Alba Mañé-Martínez, et al.. (2014). Etiologic Spectrum and Prognosis of Longitudinally Extensive Transverse Myelopathies. European Neurology. 72(1-2). 86–94. 20 indexed citations
14.
Casado, V., Lucía Romero, Elisabet Matas, et al.. (2011). PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain. Value in Health. 14(7). A320–A320. 4 indexed citations
15.
Casado, V., Lucía Romero, Elisabet Matas, et al.. (2011). PND23 Cost of the Informal Care of Multiple Sclerosis in Spain. Value in Health. 14(7). A321–A321. 2 indexed citations
16.
Martínez‐Yélamos, Sergio, Laura Bau, Elisabet Matas, et al.. (2011). Association of HLA‐DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. European Journal of Neurology. 18(10). 1258–1262. 17 indexed citations
17.
Romero, Lucía, Josep M. Pujal, Sergio Martínez‐Yélamos, et al.. (2010). Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis. Journal of the Neurological Sciences. 298(1-2). 96–100. 2 indexed citations
18.
Pujal, Josep M., Sergio Martínez‐Yélamos, Elisabet Matas, et al.. (2010). HLA‐DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. European Journal of Neurology. 18(2). 337–342. 25 indexed citations
19.
Martínez‐Yélamos, Sergio, et al.. (2009). Anticipation of age at onset in familial multiple sclerosis. European Journal of Neurology. 17(4). 572–575. 22 indexed citations
20.
Targarona, Eduardo M., et al.. (1990). Single-dose antibiotic prophylaxis in patients at high risk for infection in biliary surgery: a prospective and randomized study comparing cefonicid with mezlocillin.. PubMed. 107(3). 327–34. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Bau Breakdown of academic impact, for papers by E. P. Evdoshenko Breakdown of academic impact, for papers by Johanna Oechtering Breakdown of academic impact, for papers by M. Alba Mañé-Martínez Breakdown of academic impact, for papers by Carolina Rush Breakdown of academic impact, for papers by Elisabetta Verdun di Cantogno Breakdown of academic impact, for papers by Takeshi Kezuka Breakdown of academic impact, for papers by Johan Mellergård Breakdown of academic impact, for papers by Aidan Droogan Breakdown of academic impact, for papers by Laura Willis
Rankless by CCL
2026